Accurate classification of germinal center B-cell-like/activated B-cell-like diffuse large B-cell lymphoma using a simple and rapid reverse transcriptase-multiplex ligation-dependent probe amplification assay: A CALYM study

Journal of Molecular Diagnostics

Volumn 17, Issue 3, 2015, Pages 273-283

  Mareschal, Sylvain ^a   Ruminy, Philippe ^a   Bagacean, Cristina ^c   Marchand, Vinciane ^a   Cornic, Marie ^a,b   Jais, Jean Philippe ^d   Figeac, Martin ^f   Picquenot, Jean Michel ^a,b   Molina, Thierry Jo ^e   Fest, Thierry ^g   Salles, Gilles ^h   Haioun, Corinne ⁱ   Leroy, Karen ^j   Tilly, Hervé ^a   Jardin, Fabrice ^a  

^a UNIVERSITY OF ROUEN   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f UNIV LILLE   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ LYON 1   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j UNIVERSITÉ PARIS EST CRÉTEIL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PROTEIN BCL 2; RNA DIRECTED DNA POLYMERASE;

ARTICLE; B LYMPHOCYTE; CANCER PROGNOSIS; CLASSIFIER; COMPARATIVE STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; ENZYME IMMUNOASSAY; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GERMINAL CENTER; GOLD STANDARD; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MOLECULAR PROBE; ONCOGENE MYC; PROTEIN EXPRESSION; REVERSE TRANSCRIPTASE MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION BASED ASSAY; SURVIVAL; VALIDATION STUDY;

EID: 84928207042     PISSN: 15251578     EISSN: 19437811     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2015.01.007     Document Type: Article

References (25)

1. S.H. Swerdlow International Agency for Research on Cancer, World Health Organization WHO classification of tumours of haematopoietic and lymphoid tissues 2008 International Agency for Research on Cancer Lyon, France
2. B. Coiffier Rituximab therapy in malignant lymphoma Oncogene 26 2007 3603 3613
3. B. Coiffier, C. Thieblemont, E. Van Den Neste, G. Lepeu, I. Plantier, S. Castaigne, S. Lefort, G. Marit, M. Macro, C. Sebban, K. Belhadj, D. Bordessoule, C. Fermé, and H. Tilly Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte Blood 116 2010 2040 2045
4. A.A. Alizadeh, M.B. Eisen, R.E. Davis, C. Ma, I.S. Lossos, A. Rosenwald, J.C. Boldrick, H. Sabet, T. Tran, X. Yu, J.I. Powell, L. Yang, G.E. Marti, T. Moore, J. Hudson Jr., L. Lu, D.B. Lewis, R. Tibshirani, G. Sherlock, W.C. Chan, T.C. Greiner, D.D. Weisenburger, J.O. Armitage, R. Warnke, R. Levy, W. Wilson, M.R. Grever, J.C. Byrd, D. Botstein, P.O. Brown, and L.M. Staudt Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 403 2000 503 511
5. A.L. Shaffer 3rd, R.M. Young, and L.M. Staudt Pathogenesis of human B cell lymphomas Annu Rev Immunol 30 2012 565 610
6. S. Barton, E.A. Hawkes, A. Wotherspoon, and D. Cunningham Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks? Oncologist 17 2012 1562 1573
7. M. Roschewski, L.M. Staudt, and W.H. Wilson Diffuse large B-cell lymphoma-treatment approaches in the molecular era Nat Rev Clin Oncol 11 2014 12 23
8. D. De Jong, A. Rosenwald, M. Chhanabhai, P. Gaulard, W. Klapper, A. Lee, B. Sander, C. Thorns, E. Campo, T. Molina, A. Norton, A. Hagenbeek, S. Horning, A. Lister, J. Raemaekers, R.D. Gascoyne, G. Salles, E. Weller Lunenburg Lymphoma Biomarker Consortium Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium J Clin Oncol 25 2007 805 812
9. G. Salles, D. de Jong, W. Xie, A. Rosenwald, M. Chhanabhai, P. Gaulard, W. Klapper, M. Calaminici, B. Sander, C. Thorns, E. Campo, T. Molina, A. Lee, M. Pfreundschuh, S. Horning, A. Lister, L.H. Sehn, J. Raemaekers, A. Hagenbeek, R.D. Gascoyne, and E. Weller Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium Blood 117 2011 7070 7078
10. G. Gutiérrez-García, T. Cardesa-Salzmann, F. Climent, E. González-Barca, S. Mercadal, J.L. Mate, J.M. Sancho, L. Arenillas, S. Serrano, L. Escoda, S. Martínez, A. Valera, A. Martínez, P. Jares, M. Pinyol, A. García-Herrera, A. Martínez-Trillos, E. Giné, N. Villamor, E. Campo, L. Colomo, A. López-Guillermo Grup per l'Estudi dels Limformes de Catalunya l Balears (GELCAB) Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Blood 117 2011 4836 4843
11. I.S. Lossos, D.K. Czerwinski, A.A. Alizadeh, M.A. Wechser, R. Tibshirani, D. Botstein, and R. Levy Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes N Engl J Med 350 2004 1828 1837
12. A.A. Alizadeh, A.J. Gentles, A.J. Alencar, C.L. Liu, H.E. Kohrt, R. Houot, M.J. Goldstein, S. Zhao, Y. Natkunam, R.H. Advani, R.D. Gascoyne, J. Briones, R.J. Tibshirani, J.H. Myklebust, S.K. Plevritis, I.S. Lossos, and R. Levy Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment Blood 118 2011 1350 1358
13. L.M. Rimsza, G. Wright, M. Schwartz, W.C. Chan, E.S. Jaffe, R.D. Gascoyne, E. Campo, A. Rosenwald, G. Ott, J.R. Cook, R.R. Tubbs, R.M. Braziel, J. Delabie, T.P. Miller, and L.M. Staudt Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissues Clin Cancer Res 17 2011 3727 3732
14. S.L. Barrans, S. Crouch, M.A. Care, L. Worrillow, A. Smith, R. Patmore, D.R. Westhead, R. Tooze, E. Roman, and A.S. Jack Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome Br J Haematol 159 2012 441 453
15. N. Masqué-Soler, M. Szczepanowski, C.W. Kohler, R. Spang, and W. Klapper Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens Blood 122 2013 1985 1986
16. D.W. Scott, G.W. Wright, P.M. Williams, C.J. Lih, W. Walsh, E.S. Jaffe, A. Rosenwald, E. Campo, W.C. Chan, J.M. Connors, E.B. Smeland, A. Mottok, R.M. Braziel, G. Ott, J. Delabie, R.R. Tubbs, J.R. Cook, D.D. Weisenburger, T.C. Greiner, B.J. Glinsmann-Gibson, K. Fu, L.M. Staudt, R.D. Gascoyne, and L.M. Rimsza Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue Blood 123 2014 1214 1217
17. E. Eldering, C.A. Spek, H.L. Aberson, A. Grummels, I.A. Derks, A.F. de Vos, C.J. McElgunn, and J.P. Schouten Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways Nucleic Acids Res 31 2003 e153
18. E. Bohers, S. Mareschal, A. Bouzelfen, V. Marchand, P. Ruminy, C. Maingonnat, A.L. Ménard, P. Etancelin, P. Bertrand, S. Dubois, M. Alcantara, C. Bastard, H. Tilly, and F. Jardin Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma Genes Chromosomes Cancer 53 2014 144 153
19. F. Jardin, S. Mareschal, M. Figeac, J.P. Jais, K. Leroy, C. Copie-Bergman, G.A. Salles, B. Coiffier, R. Delarue, F. Peyrade, A. Bosly, N. Ketterer, C. Haioun, H. Tilly, and T.J. Molina Integrated analysis of high-resolution gene expression and copy number profiling identified biallelic deletion of CDKN2A/2B tumor suppressor locus as the most frequent and unique genomic abnormality in diffuse large B-cell lymphoma (DLBCL) with strong prognostic value in both GCB and ABC subtypes and not overcome by a dose-intensive immunochemotherapy regimen plus rituximab. Results of a Prospective GELA Clinical Trial Program ASH Annual Meeting Abstracts 120 2012 415
20. C.P. Hans, D.D. Weisenburger, T.C. Greiner, R.D. Gascoyne, J. Delabie, G. Ott, H.K. Müller-Hermelink, E. Campo, R.M. Braziel, E.S. Jaffe, Z. Pan, P. Farinha, L.M. Smith, B. Falini, A.H. Banham, A. Rosenwald, L.M. Staudt, J.M. Connors, J.O. Armitage, and W.C. Chan Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray Blood 103 2004 275 282
21. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B 57 1995 289 300
22. N.A. Johnson, G.W. Slack, K.J. Savage, J.M. Connors, S. Ben-Neriah, S. Rogic, D.W. Scott, K.L. Tan, C. Steidl, L.H. Sehn, W.C. Chan, J. Iqbal, P.N. Meyer, G. Lenz, G. Wright, L.M. Rimsza, C. Valentino, P. Brunhoeber, T.M. Grogan, R.M. Braziel, J.R. Cook, R.R. Tubbs, D.D. Weisenburger, E. Campo, A. Rosenwald, G. Ott, J. Delabie, C. Holcroft, E.S. Jaffe, L.M. Staudt, and R.D. Gascoyne Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone J Clin Oncol 30 2012 3452 3459
23. G. Lenz, G. Wright, S.S. Dave, W. Xiao, J. Powell, H. Zhao Lymphoma/Leukemia Molecular Profiling Project Stromal gene signatures in large-B-cell lymphomas N Engl J Med 359 2008 2313 2323
24. G. Wright, B. Tan, A. Rosenwald, E.H. Hurt, A. Wiestner, and L.M. Staudt A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma Proc Natl Acad Sci U S A 100 2003 9991 9996
25. G.P. Patrinos Molecular diagnostics 2010 Academic Press Amsterdam